Anderson Zago

Dr. Anderson Zago


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
AMAnderson Macedo
Anderson Macedo
AKAndré L.O. Krug
André L.O. Krug
NHNaiara A. Herrera
Naiara A. Herrera
AZAnderson Zago
Anderson Zago
JRJames W.E. Rush
James W.E. Rush
SASandra Lia Amaral
Sandra Lia Amaral

10 September 2015 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
AKAndré L.O. Krug
André L.O. Krug
AMAnderson G. Macedo
Anderson G. Macedo
AZAnderson Zago
Anderson Zago
JRJames W.E. Rush
James W.E. Rush
CSCarlos F. Santos
Carlos F. Santos
SASandra Lia Amaral
Sandra Lia Amaral

8 July 2010 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
AZAnderson Zago
Anderson Zago
LSLeonardo dos Reis Silveira
Leonardo dos Reis Silveira
EKEduardo Kokubun
Eduardo Kokubun

1 March 2016 in Steroids
Verified
Journal Article
Closed access
AMAnderson G. Macedo
Anderson G. Macedo
AKAndré Luis O. Krug
André Luis O. Krug
LSLidiane Moreira Souza
Lidiane Moreira Souza
AMAline M. Martuscelli
Aline M. Martuscelli
PCPaula B. Constantino
Paula B. Constantino
SASandra Lia Amaral
Sandra Lia Amaral

1 December 2006 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
AZAnderson Zago
Anderson Zago
AZAngelina Zanesco
Angelina Zanesco

14 January 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
EMElvis de Souza Malta
Elvis de Souza Malta
FLFabio Santos de Lira
Fabio Santos de Lira
FMFabiana Andrade Machado
Fabiana Andrade Machado
AZAnderson Zago
Anderson Zago
SASandra Lia Amaral
Sandra Lia Amaral
AZAlessandro Moura Zagatto
Alessandro Moura Zagatto
Purpose: The aim of the present study was to investigate the effectiveness of photobiomodulation therapy (PBMT) on muscle recovery based on inflammation (interleukin-10 [IL-10]; tumor necrosis factor-α [TNFα]), muscle damage markers (creatine kinase [CK]; lactate dehydrogenase [LDH]), delay onset muscle soreness (DOMS), and countermovement jump performance (CMJ) after two sprint interval training (SIT) sessions compared with a placebo condition (part-I), as well as to compare the effectiveness of PBMT with active recovery (AR) and cold-water immersion (CWI) (part-II). Methods: Part-I was conducted as a double-blind, randomized and placebo-controlled study and part-II as a parallel-group study. Thirty-six men participated in the studies (12 participants in part-I and 36 participants in part-II). Volunteers performed two SITs interspaced by 24-h (SIT1 and SIT2) to mimic the effect of accumulating 2 consecutive days of SIT. In part-I, only after SIT2, PBMT [Total energy: 600J (300J per leg in 5 spots); wavelength: 660–850 nm] or placebo interventions were performed, while in part-II PBMT (part-I data), AR (15-min; 50% of the maximal aerobic power), or CWI (10-min; 10°C) were carried out, also after SIT2. Blood samples were collected before (i.e., baseline), and 0.5, 1, 24, 48, and 72-h after SIT2, while CMJ and DOMS were measured before, 24, 48, and 72-h after SIT2. Results: In part-I, there were no interactions between PBMT and placebo conditions for any blood markers (P ≥ 0.313), DOMS (P = 0.052), and CMJ (P = 0.295). However, an effect of time was found with increases in LDH, CK, and IL-10 (P ≤ 0.043) as well as a decrease in DOMS at 72-h compared with 24-h (P = 0.012). In part-II, there were no interactions between the PBMT, AR, and CWI groups for any markers at the same moments (P ≥ 0.189) and for the peak and integral values (P ≥ 0.193), for DOMS (P = 0.314) and CMJ (P = 0.264). However, an effect of time was found with an increase in CK and IL-10 (P = 0.003), while DOMS decreased at 48 and 72-h compared with 24-h (P = 0.001). Conclusion: In summary, PBMT had no effect on inflammation, muscle damage, CMJ performance, or DOMS after two consecutive sprint interval training sessions compared to placebo, CWI, and AR strategies.